Randomized Phase Ii Trial Of Bevacizumab And Temsirolimus In Combination With Vinorelbine (V) And Cyclophosphamide (C) For First Relapse/Disease Progression Of Rhabdomyosarcoma (Rms): A Report From The Children'S Oncology Group (Cog).